Key facts
- This page summarizes Greg Petersen's Form 4 filing for PLUS THERAPEUTICS, INC. (PSTV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Sep 2024, 06:04.
Greg Petersen - 11 Sep 2024 Form 4 Insider Report for PLUS THERAPEUTICS, INC. (PSTV)
- Reporting relationship
- Director
- Issuer ticker
- PSTV
- Reported as of
- 11 Sep 2024
- Net transaction value
- +$16,875
- SEC form
- 4
- Accepted by SEC
- 13 Sep 2024, 06:04:12 UTC
- Prior SEC filing
- 15 May 2024
- Next SEC filing
- 20 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Sims, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Greg Petersen filed Form 4 for PLUS THERAPEUTICS, INC. (PSTV) on 13 Sep 2024.
Change
- Previous filing in this sequence was filed on 15 May 2024.
- Current net transaction value: +$16,875.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PSTV
transaction
Common Stock
Purchase
- Transaction value
- $16,875
- Shares
- +12,500
- Change %
- +34%
- Price
- $1.35
- Shares after
- 48,921
- Date
- 11 Sep 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.